Lista de obras -

A perspective on B-cell-targeting therapy for SLE.

artículo científico publicado en 2009

Altered B cell receptor signaling in human systemic lupus erythematosus

artículo científico publicado en 2008

Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.

artículo científico publicado en 2011

B cell depletion therapy in autoimmune diseases

artículo científico publicado en 2007

B cell depletion therapy in systemic lupus erythematosus

artículo científico publicado en 2003

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny

artículo científico publicado en 2006

B cell therapies for rheumatoid arthritis: beyond B cell depletion

artículo científico publicado en 2010

B cells and immunological tolerance.

scientific article published on February 2009

B cells as therapeutic targets in SLE.

artículo científico publicado en 2010

B cells in human and murine systemic lupus erythematosus

artículo científico publicado en 2004

B-cell-depleting therapy in systemic lupus erythematosus

artículo científico publicado en 2012

Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library

artículo científico publicado en 2003

Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults ⬇️

artículo científico publicado el 27 de octubre de 2010

Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect

artículo científico publicado en 2011

Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks

artículo científico publicado en 2008

Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity

artículo científico publicado en 2016

Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus

artículo científico publicado en 2015

Dysregulation of germinal centres in autoimmune disease.

artículo científico publicado en 2009

Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study

artículo científico publicado en 2010

Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response

artículo científico publicado en 2015

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

artículo científico publicado en 2020

Extrafollicular responses in humans and SLE

scientific article published on 01 March 2019

Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation

artículo científico publicado en 2011

Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

artículo científico publicado en 2005

Human innate B cells: a link between host defense and autoimmunity?

artículo científico publicado en 2005

Indications of rituximab in autoimmune diseases

artículo científico publicado en 2009

Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets

artículo científico publicado en 2009

Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow

artículo científico publicado en 2015

Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes

artículo científico publicado en 2004

Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.

artículo científico publicado en 2013

New therapies for systemic lupus erythematosus: cellular targets

artículo científico publicado en 2006

Novel human transitional B cell populations revealed by B cell depletion therapy

artículo científico publicado en 2009

OMIP‐003: Phenotypic analysis of human memory B cells ⬇️

artículo científico publicado el 27 de julio de 2011

Phenotypic and functional heterogeneity of human memory B cells

artículo científico publicado en 2008

Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells

artículo científico publicado en 2014

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

artículo científico publicado en 2020

Rationale for B cell targeting in SLE

artículo científico publicado en 2014

Reconstitution of the adult B cell repertoire after treatment with rituximab

artículo científico publicado en 2005

Role of Myocardial Collagen in Severe Aortic Stenosis With Preserved Ejection Fraction and Symptoms of Heart Failure

artículo científico publicado en 2017

Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion

artículo científico publicado en 2012

Systemic lupus erythematosus: Extent and patterns of off-label use of rituximab for SLE. ⬇️

artículo científico publicado en 2016

Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?

artículo científico publicado en 2010

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus

artículo científico publicado en 2003

Treatment of SLE with anti-CD20 monoclonal antibody

artículo científico publicado en 2005

Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach.

artículo científico publicado en 2018

Understanding and measuring human B-cell tolerance and its breakdown in autoimmune disease

scientific article published on 22 November 2019

Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome ⬇️

artículo científico publicado el 1 de septiembre de 2012

Lista de obras de

A perspective on B-cell-targeting therapy for SLE.

Altered B cell receptor signaling in human systemic lupus erythematosus

Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.

B cell depletion therapy in autoimmune diseases

B cell depletion therapy in systemic lupus erythematosus

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny

B cell therapies for rheumatoid arthritis: beyond B cell depletion

B cells and immunological tolerance.

B cells as therapeutic targets in SLE.

B cells in human and murine systemic lupus erythematosus

B-cell-depleting therapy in systemic lupus erythematosus

Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library

Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults ⬇️

Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect

Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks

Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity

Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus

Dysregulation of germinal centres in autoimmune disease.

Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study

Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

Extrafollicular responses in humans and SLE

Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation

Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

Human innate B cells: a link between host defense and autoimmunity?

Indications of rituximab in autoimmune diseases

Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets

Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow

Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes

Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.

New therapies for systemic lupus erythematosus: cellular targets

Novel human transitional B cell populations revealed by B cell depletion therapy

OMIP‐003: Phenotypic analysis of human memory B cells ⬇️

Phenotypic and functional heterogeneity of human memory B cells

Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

Rationale for B cell targeting in SLE

Reconstitution of the adult B cell repertoire after treatment with rituximab

Role of Myocardial Collagen in Severe Aortic Stenosis With Preserved Ejection Fraction and Symptoms of Heart Failure

Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion

Systemic lupus erythematosus: Extent and patterns of off-label use of rituximab for SLE. ⬇️

Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus

Treatment of SLE with anti-CD20 monoclonal antibody

Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach.

Understanding and measuring human B-cell tolerance and its breakdown in autoimmune disease

Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome ⬇️